Heart Failure & Arrhythmias
Studies of normal cardiac function and pathogenesis to improve diagnosis, treatment, and prevention of heart failure and arrhythmias; translation of promising scientific and technological advances. Supported areas: heart failure, arrhythmias, myocardial protection, cardiotoxicity, and resuscitation science.
Program Officers
Bishow Adhikari, Ph.D.
Cardiotoxicity; cardiomyopathy; heart failure
301-594-2791
Patrice Desvigne-Nickens, M.D.
Health disparities; cardio-oncology; clinical trials
301-435-0504
Fassil Ketema, M.Sc.
HIV-associated Cardiovascular Diseases, Clinical Trials, Syndemics
301-496-5468
Coralie Poizat, Ph.D.
Heart failure; cardiomyopathy; epigenomics
301-451-3945
Sujata Shanbhag, M.D.
Cardiovascular imaging (CT, MRI); atherothrombosis; clinical trials
301-435-0504
Yang (Scarlet) Shi, Ph.D.
Myocardial protection; heart failure; cardiotoxicity
301-435-0455
Emily Tinsley, Ph.D.
Rehabilitation; exercise physiology; clinical trials
301-435-0519